Business Model & Revenue
Solidion Technology, Inc. (NASDAQ: STI) is a Dallas, Texas-based battery technology company founded in June 2023. The company develops solid-state battery materials, silicon anodes, and pouch cell technologies for energy storage systems and electric vehicle applications.
Product pipeline: The company claims to be developing solid-state battery components including electrolytes, anode materials, and pouch cell formats. Management has guided for commercial product launches in Q1-Q2 2026, but no commercial products have been launched as of June 2026.
Revenue model: Currently generates minimal revenue ($100K TTM, likely from consulting, grants, or early-stage licensing). Future revenue model intended to be battery material sales, licensing fees, and pouch cell supply agreements.
Patent monetization: In April 2026, STI entered a binding agreement with Hilco Global to monetize its "foundational energy portfolio" through licensing and enforcement. Hilco identified "high-value assets" but the agreement guarantees no specific revenue.
Non-binding MOU: In February 2026, STI entered a non-binding MOU to supply pouch cells for energy storage systems. The potential revenue is $4-6M over 12 months, but there is no purchase order, no binding commitment, and no guarantee.
The company completed a restructuring eliminating Series C/D pre-funded warrants and converting major holders to common stock. It has received government grants and patents, but no commercial product revenue.
Financial Highlights
Income Statement
| Metric | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | $0.10M | $0.01M | -$0.01M | — |
| Gross Profit | $0.09M | $0.01M | -$0.01M | — |
| SG&A | $9.18M | $9.51M | $0.92M | $2.31M |
| R&D | $2.47M | $3.42M | $2.38M | $3.02M |
| Operating Income | ($11.56)M | ($12.92)M | ($13.30)M | ($5.32)M |
| Net Income | ($7.64)M | ($41.00)M | ($32.42)M | ($5.32)M |
| FCF | ($2.40)M | ($4.65)M | ($7.38)M | ($4.07)M |
Key Metrics
| Metric | Value |
|---|---|
| Market Cap (post-surge) | ~$22M |
| Shares Outstanding | 7.75M |
| Price/Sales (TTM) | 220x |
| Pre-surge Price | ~$0.77 |
| 10-K Status | DELAYED (due May 18) |
| Quarterly Filing Status | DELAYED |
| Founded | June 2023 |
| Patents | Multiple (quantity unspecified) |
| Employees | ~30-50 (estimated) |
The Dilution History
| Year | Shares | Growth |
|---|---|---|
| FY2022 | 0.06M | — |
| FY2023 | 1.40M | +2,233% |
| FY2024 | 2.63M | +88% |
| FY2025 | 7.47M | +184% |
| Current | 7.75M | +4% |
| Total | 0.06M → 7.75M | +12,817% |
R&D vs. Solid-State Battery Peers
| Company | Annual R&D | Market Cap |
|---|---|---|
| QuantumScape (QS) | $100M+ | $1.5B |
| Solid Power (SLDP) | $50M+ | $400M |
| SES AI (SES) | $60M+ | $1.2B |
| STI | $2.47M | $22M |
STI spends 1/40th of what legitimate solid-state battery companies spend on R&D. You cannot develop solid-state batteries on $2.47M/year.
Competitive Landscape
The solid-state battery space is dominated by well-funded companies with years of development:
- QuantumScape (QS): $1.5B market cap, $100M+ annual R&D. Backed by Volkswagen. closest to commercialization.
- SES AI (SES): $1.2B market cap, $60M+ annual R&D. Hybrid lithium-metal technology. Backed by GM, Hyundai.
- Solid Power (SLDP): $400M market cap, $50M+ annual R&D. Sulfide solid electrolyte technology. Partnership with BMW and Ford.
- ProLogium: Taiwanese solid-state battery company. Partnership with Mercedes-Benz. $2B+ valuation.
- Toyota (TM): Developing solid-state batteries internally with $13B+ annual R&D budget across all technologies.
STI's competitive position: Non-existent. With $2.47M in annual R&D, STI cannot compete in solid-state battery development against companies spending 20-40x more. The company's patents may have value (hence the Hilco partnership), but patent ownership is not the same as commercial capability.
The pouch cell market: Pouch cells are a commodity battery format manufactured by companies like CATL, LG Energy Solution, and Samsung SDI at massive scale. STI claiming to supply pouch cells from a company with $100K revenue and 50 employees is like a lemonade stand claiming to supply Coca-Cola.
Catalysts
-
Pouch cell MOU converts to binding contract: If the non-binding MOU becomes a firm purchase order, it validates the supply capability. Timing uncertain.
-
Hilco patent monetization revenue: Any licensing or enforcement revenue from the Hilco partnership. No guaranteed amount or timing.
-
SEC filings completed: If the delayed 10-K and quarterly reports are filed without adverse findings, the filing overhang resolves.
-
Commercial product launch: Management has guided for Q1-Q2 2026 commercial timing for new products. No evidence of launch yet.
-
Section 337 Tariff Act outcome: If the complaint succeeds, it could provide patent protection advantages.
Reality: Every catalyst is forward-looking, uncertain, and unquantified. The company has never delivered on any announced timeline. The "Q1-Q2 2026 commercial launch" has already been missed (it's June 2026).
Key Risks
- Delayed SEC filings (10-K due May 18, quarterly reports also late). Delayed filings indicate accounting issues or material uncertainties.
- Non-binding MOU for pouch cell supply. No guaranteed purchase commitment, no firm timeline, no penalty for non-performance.
- $100K TTM revenue. Zero commercial products after 3 years of operation.
- $7.64M annual net loss. Cash burn requires continuous stock dilution.
- 12,817% share dilution: 0.06M shares (FY2022) → 7.75M shares (FY2025).
- Hilco patent deal guarantees no specific revenue or timing. Patent monetization is slow and uncertain.
- $2.47M annual R&D is trivial for solid-state battery development. QuantumScape spends $100M+/year.
- Section 337 Tariff Act complaint filed — additional legal complexity and cost.
- Company founded June 2023 — less than 3 years old with no track record.
- No analyst coverage, no institutional following, no partnerships with major OEMs.
Our Thesis
STI has four致命 problems, each individually disqualifying:
-
Delayed SEC filings. The 10-K (due May 18) and quarterly reports are late. Companies delay filings when there are accounting issues, auditor disagreements, or material uncertainties they need to resolve. For a pre-revenue company founded in 2023, delayed filings are a major red flag. What are they hiding or struggling to report?
-
Non-binding MOU. The pouch cell supply agreement is non-binding — it's a letter of intent, not a contract. "Potentially $4-6M revenue" has no guarantee, no purchase order, no timeline. Management can walk away with no consequence. Non-binding MOUs are the cheapest form of corporate hype.
-
Zero revenue. $100K TTM revenue on $7.64M in losses. The company has been operating for three years and cannot generate revenue from a commercial product. R&D spend is $2.47M/year — modest for a company claiming to develop solid-state battery technology, which requires hundreds of millions in capital.
-
Massive dilution. Shares grew from 0.06M (FY2022) to 7.75M (FY2025) — that's 12,817% dilution in three years. The company funds itself by printing stock. The "restructuring" that eliminated Series C/D warrants converted major holders to common — more dilution.
The Hilco patent deal is the only legitimate piece of news. Hilco Global is a real IP monetization firm. But the agreement "does not guarantee specific revenue amounts or timing." Patent monetization takes years and produces uncertain outcomes.
The solid-state battery space is legitimate and will produce winners. But Solidion's $2.47M in annual R&D doesn't build a battery company — it builds PowerPoint decks. Real solid-state battery companies (QuantumScape, Solid Power, SES AI) spend $50-100M+ per year on R&D. STI is not in that league.
Get reports like this delivered free
New small-cap research every week. No paywall, no fluff.